PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. (Q44559505)

4 December 2017

title

PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. (English)

1 reference

4 December 2017

1 reference

Steffen Frese

1

1 reference

4 December 2017

Farzaneh Pirnia

2

1 reference

4 December 2017

Daniela Miescher

3

1 reference

4 December 2017

Stan Krajewski

4

1 reference

4 December 2017

Markus M Borner

5

1 reference

4 December 2017

John C Reed

6

1 reference

4 December 2017

Ralph A Schmid

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

22

1 reference

4 December 2017

issue

35

1 reference

4 December 2017

page(s)

5427-5435

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

Follicle-stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kDa phosphotyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

New insights into the control of MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

The role of c-FLIP in modulation of CD95-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

Requirement for ERK activation in cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

MEK inhibition enhances paclitaxel-induced tumor apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Triptolide induces apoptotic death of T lymphocyte

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206842

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206842

1 reference

4 December 2017

1 reference